Adverse Drug Reactions

The following adverse reactions may occur. Patients should be carefully monitored, and appropriate therapeutic measures, such as discontinuing the administration, should be taken if any abnormalities are observed.

0.1%-5% <0.1%
Gastrointestinal Anorexia, nausea/vomiting and diarrhea
Hypersensitivitynote) Rash
Note) The incidence of adverse reactions includes the post-marketing surveillance


Reporting of suspected adverse drug reactions
Please contact:
HI-Eisai Pharmaceutical, Inc.
+63 2 88875837 / +63 2 88875160 / +63 9088672236
Or Report to FDA Philippines: